ERROR! No headcode.htm file found.

School of Medicine


Showing 1-50 of 154 Results

  • Bruce T. Adornato

    Bruce T. Adornato

    Adjunct Clinical Professor, Neurology & Neurological Sciences

    Bio Dr. Adornato joined the Department of Neurology as Voluntary Clinical Faculty in 1978, (subsequently Adjunct Clinical Faculty) and has served as Director of the Neuromuscular Laboratory from 1978 until 1983, performing and interpreting nerve and muscle biopsies as well as serving as attending physician directing residents and medical students in the diagnosis and care of his private patients admitted to Stanford Hospital. Since 1986, he has been attending physician at the Palo Alto VA Hospital, directing Stanford Neurology residents and medical students in the care of veterans. He has published 69 peer reviewed papers and a number of book chapters in the field of neurology. He is currently the medical officer of a silicon valley startup exploring mobility devices for the neurologically impaired.

  • Gregory W. Albers, MD

    Gregory W. Albers, MD

    The Coyote Foundation Professor and Professor, by courtesy, of Neurosurgery

    Current Research and Scholarly Interests Our group’'s research focus is the acute treatment and prevention of cerebrovascular disorders. Our primary interest is the use of advanced imaging techniques to expand the treatment window for ischemic stroke. We are also conducting clinical studies of both neuroprotective and thrombolytic strategies for the treatment of acute stroke and investigating new antithrombotic strategies for stroke prevention.

  • Katrin Andreasson

    Katrin Andreasson

    Professor of Neurology

    Current Research and Scholarly Interests Our research focuses on understanding how immune responses initiate and accelerate synaptic and neuronal injury in age-related neurodegeneration, including models of Alzheimer's disease and Parkinson's disease. We also focus on the role of immune responses in aggravating brain injury in models of stroke. Our goal is the identification of critical immune pathways that function in neurologic disorders and that can be targeted to elicit disease modifying effects.

  • Meredith Barad, MD

    Meredith Barad, MD

    Clinical Associate Professor, Anesthesiology, Perioperative and Pain Medicine

    Current Research and Scholarly Interests My current research interests involve novel treatment paradigms for challenging pain problems such as orofacial pain, trigeminal neuralgia and low pressure headaches. I am also interested in migraine and trigeminal autonomic cephalgias and their intersection with chronic pain.

  • Fiona Baumer

    Fiona Baumer

    Assistant Professor of Neurology

    Current Research and Scholarly Interests Causes of Disturbed Cognition in Pediatric Epilepsy

  • Helen Bronte-Stewart, MD, MS

    Helen Bronte-Stewart, MD, MS

    John E. Cahill Family Professor, Professor of Neurology and, by courtesy, of Neurosurgery

    Current Research and Scholarly Interests My research focus is human motor control and brain pathophysiology in movement disorders. Our overall goal is to understand the role of the basal ganglia electrical activity in the pathogenesis of movement disorders. We have developed novel computerized technology to measure fine, limb and postural movement. With these we are measuring local field potentials in basal ganglia nuclei in patients with Parkinson's disease and dystonian and correlating brain signalling with motor behavior.

  • Axel Brunger

    Axel Brunger

    Professor of Molecular and Cellular Physiology, of Neurology, of Photon Science and, by courtesy, of Structural Biology

    Current Research and Scholarly Interests One of Axel Brunger's major goals is to decipher the molecular mechanisms of synaptic neurotransmitter release by conducting imaging and single-molecule/particle reconstitution experiments, combined with near-atomic resolution structural studies of the synaptic vesicle fusion machinery.

  • Paul Buckmaster, DVM, PhD

    Paul Buckmaster, DVM, PhD

    Professor of Comparative Medicine and of Neurology

    Current Research and Scholarly Interests Mechanisms of epilepsy, especially temporal lobe epilepsy.

  • Marion S. Buckwalter, MD, PhD

    Marion S. Buckwalter, MD, PhD

    Professor of Neurology and of Neurosurgery

    Current Research and Scholarly Interests The goal of the Buckwalter Lab is to improve how people recover after a stroke. We use basic research to understand the cells, proteins, and genes that lead to successful recovery of function, and also how complications develop that impact quality of life after stroke. Ongoing projects are focused on understanding how inflammatory responses are regulated after a stroke and how to make recovery faster and better after stroke.

  • Michelle Thi Cao

    Michelle Thi Cao

    Clinical Associate Professor, Neurology & Neurological Sciences

    Current Research and Scholarly Interests Positive Airway Pressure devices for central sleep apnea

  • Steven D. Chang, MD

    Steven D. Chang, MD

    Robert C. and Jeannette Powell Neurosciences Professor and, by courtesy, of Otolaryngology - Head & Neck Surgery (OHNS) and of Neurology

    Current Research and Scholarly Interests Clinical research includes studies in the treatment of cerebrovascular disorders, such as aneurysms and AVMs, as well as the use of radiosurgery to treat tumors and vascular malformations of the brain and spine.

    Dr. Chang is C0-Director of the Cyberknife Radiosurgery Program.

    Dr. Chang is also the head of the The Stanford Neuromolecular Innovation Program with the goal of developing new technologies to improve the diagnosis and treatment of patients affected by neurological conditions.

  • S. Charles Cho, MD

    S. Charles Cho, MD

    Clinical Professor, Neurology & Neurological Sciences

    Current Research and Scholarly Interests Clinical research focused on peripheral nerve and muscle disorders. Also involved with prevention of cerebrovascular disesase in the intraoperative setting. Ongoing clincial studies include treatments for Amyotrophic Lateral Sclerosis (ALS), Inflammatory Demyelinating Neuropathy and HIV neuropathic pain.

  • Robert Cowan, MD, FAAN

    Robert Cowan, MD, FAAN

    Clinical Professor, Neurology & Neurological Sciences

    Current Research and Scholarly Interests Current interest focus on patient education technology and patient/physician communication with a particular emphasis on tools which increase encounter efficiency and improve outcomes. Basic research focuses on mechanisms of action in Chronic Daily Headache, with a particular emphasis on New Daily Persistent Headache. Techniques include fMRI, biomarker investigation and evoked potentials. Clinical research includes clinical trials of novel treatments for episodic and chronic headache forms.

  • John W. Day, MD, PhD

    John W. Day, MD, PhD

    Professor of Neurology, of Pediatrics (Genetics) and, by courtesy, of Pathology

    Current Research and Scholarly Interests Our Neuromuscular Division coordinates a comprehensive effort to conquer peripheral nerve and muscle disorders, including the muscular dystrophies, motor neuron disorders, neuromuscular junction abnormalities, and peripheral neuropathies. With patients and families foremost in mind, we have had success defining and combating these diseases, with research focused on identifying genetic causes, developing novel treatment, and maximizing patient function by optimizing current management.

  • Antoine de Morree

    Antoine de Morree

    Instructor, Neurology & Neurological Sciences

    Current Research and Scholarly Interests Molecular mechanisms underlying neuromuscular disorders and the molecular regulation of satellite cell quiescence and activation in relation to normal aging.

  • Jun Ding

    Jun Ding

    Associate Professor of Neurosurgery and of Neurology

    Current Research and Scholarly Interests Neural circuits of movement control in health and movement disorders

  • Les Dorfman, MD

    Les Dorfman, MD

    Professor of Neurology and Neurological Sciences, Emeritus

    Current Research and Scholarly Interests Clinical electrophysiology of the peripheral and central nervous systems, including nerve conduction velocity; electromyography (EMG); and visual, auditory and somatosensory evoked potentials. Multiple sclerosis (MS) diagnosis and treatment. Neurological education.

  • Dawn Duane

    Dawn Duane

    Clinical Associate Professor, Neurology & Neurological Sciences

    Current Research and Scholarly Interests I am a general pediatric neurologist. My interest is in clinical diagnosis and treatment of common neurologic diseases in pediatric patients and teaching feature doctors, neurologists and pediatric neurologists about pediatric neurology.

  • Jeffrey Dunn, MD

    Jeffrey Dunn, MD

    Clinical Professor, Neurology & Neurological Sciences

    Current Research and Scholarly Interests Translational research in the human application of emerging immunotherapies for neurological disease, focusing on Multiple Sclerosis, CIS, transverse myelitis and Neuromyelitis Optica (NMO). Collaborative research with Stanford and extramural scientific faculty to identify biomarkers of disease activity and treatment response in humans. Clinical trials to assess efficacy of emerging treatments for MS, CIS and NMO.

  • Emmanuel During, MD

    Emmanuel During, MD

    Clinical Associate Professor, Psychiatry and Behavioral Sciences - Stanford Center for Sleep Sciences and Medicine

    Current Research and Scholarly Interests Improving diagnostics and therapeutics in RBD, using home ambulatory devices including wearable actigraphy, dry-EEG, to power clinical trials based on objective outcomes of RBD activity.

    Controlling symptoms of RBD testing drugs rigorously.

    Predicting the course of neurodegeneration using deep phenotyping using clinical and serum biomarkers, measures of autonomic impairment, skin biopsy, microbiome

  • Sarah Eagleman

    Sarah Eagleman

    Instructor, Neurology & Neurological Sciences

    Bio For over a decade my research career as a systems neuroscientist has been centered on measuring the brain in different states of consciousness using electrophysiology. Two ways to study conscious transitions empirically are by investigating the brain during sleep and while under anesthesia. I spent my doctoral and early postdoctoral work studying how sleep improves learning and memory at the neural network level. Currently, I study the brain activity associated with anesthetic state transitions to broaden my understanding of the neural dynamics associated with altered conscious states. In fact, the brain shares similar electrophysiological activity patterns during sleep with some anesthetic transitions. With anesthetics, however, one can compare how different anesthetic agents interact with different neuromodulatory systems to cause similar behavioral outcomes (i.e. sedation and unconsciousness).

    My current projects include exploring and evaluating different computational approaches to quantify anesthetic depth using electrophysiology in various anesthetic protocols, identifying perioperative anesthesia risk factors for poor cognitive outcomes, and understanding the influence of anesthesia on neural circuits in patients with epilepsy. A thorough characterization of the brain activity associated with brain state transitions during anesthesia administration is of critical importance to better monitor patients and improve outcomes.

  • Alex N. Eischeid, MD

    Alex N. Eischeid, MD

    Clinical Assistant Professor, Neurology & Neurological Sciences

    Bio Dr. Eischeid is a board-certified neurologist and a clinical assistant professor in the Department of Neurology, Division of Movement Disorders at Stanford University School of Medicine. He specializes in the management of a wide range of neurological conditions. His focus is on movement disorders, including Parkinson?s disease, atypical parkinsonism, Huntington?s disease, ataxia, dystonia, and tremor. He has advanced training in botulinum toxin injections for dystonia and spasticity. Dr. Eischeid also delivers expertise in deep brain stimulation programming. With each patient, his goal is to safely and effectively relieve symptoms while improving quality of life.

    Dr. Eischeid has been a presenter at the Stanford Alzheimer?s Disease Research Center Neuropathology Case Conference. He also has participated in meetings of the Movement Disorders Society and American Academy of Neurology.

    Scholarship activities of Dr. Eischeid include writing peer-reviewed articles on topics such as the intracellular signaling that enables microglia to increase neurogenesis. His work has appeared in BMC Neuroscience, the Journal of Immunology, PLoS One, and elsewhere.

    Among his honors, Dr. Eischeid received the Resident Fincham Award, given to a graduating neurology resident who best exemplifies the qualities of dedicated patient care and the highest level of collegiality. He was also named Administrative Chief Neurology Resident, an awarded position based on leadership qualities and academic performance. As a senior resident, he earned recognition as the ?Best Resident On-Call.? Dr. Eischeid is a member of the American Academy of Neurology and Movement Disorders Society. He served on the Board of Directors of the Iowa Neurological Association. In his personal time, Dr. Eischeid has provided volunteer medical services at homeless shelters.

  • Faisal Fecto

    Faisal Fecto

    Instructor, Neurology & Neurological Sciences

    Bio Dr. Fecto is a board-certified neurologist and neuromuscular medicine specialist. Dr. Fecto completed his medical training at the Aga Khan University in Pakistan in 2005, where he was also junior faculty till 2006. Dr. Fecto completed his PhD in neuroscience at Northwestern University in 2012 during which he was supported by a University Fellowship and an NIH/NIA Ruth L. Kirschstein National Research Service Award Predoctoral Fellowship. From 2012 to 2015 he completed his post-doctoral training in neurogenetics at Northwestern University as the Link Foundation Fellow. Dr. Fecto completed his neurology residency and chief residency at the University of Iowa Hospitals and Clinics as part of the clinical-neuroscientist and physician-scientist training programs. Dr. Fecto completed his fellowship in neuromuscular medicine at Stanford University in 2020.

    Dr. Fecto has received several awards including the resident teaching award, resident team leader award, a resident lectureship by the Iowa Neurological Association, and a fellow scholarship by the American Academy of Neurology. Dr. Fecto is a well-published researcher and serves as an associate editor for the journal BMC Neurology. His research explores the pathogenic mechanisms that contribute to neuromuscular disorders such as amyotrophic lateral sclerosis and myotonic dystrophy. His research is supported by an NIH/NINDS R25 Research Education Grant. Dr. Fecto is a member of Alpha Omega Alpha Honor Medical Society, Sigma Xi Scientific Research Honor Society, American Academy of Neurology, American Association of Neuromuscular and Electrodiagnostic Medicine, Society for Neuroscience, American Association for the Advancement of Science, and the American Medical Association.

  • Anna Finley Caulfield, MD

    Anna Finley Caulfield, MD

    Clinical Associate Professor, Neurology & Neurological Sciences

    Current Research and Scholarly Interests Dr. Finley joined the Stanford Stroke Center in 2004 from Beth Israel Deaconess Medical Center in Boston. She cares for acute stroke patients and other neurologically critical ill patients in the intensive care unit. Currently, her research interests include hypothermia after cardiac arrest and comparing health care provider's predications of future neurological function in neurologically critical ill patients to their 6-month outcome.

  • Paul Graham Fisher, MD

    Paul Graham Fisher, MD

    Beirne Family Professor of Pediatric Neuro-Oncology, Professor of Pediatrics and, by courtesy, of Neurosurgery and of Epidemiology and Population Health

    Current Research and Scholarly Interests Clinical neuro-oncology: My research explores the epidemiology, natural history, and disease patterns of brain tumors in childhood, as well as prospective clinical trials for treating these neoplasms. Research interests also include neurologic effects of cancer and its therapies, and childhood headaches.

  • Robert Fisher, MD, PhD

    Robert Fisher, MD, PhD

    The Maslah Saul Professor in the Department of Neurology and Professor, by courtesy, of Neurosurgery

    Current Research and Scholarly Interests Dr. Fisher is interested in clincal, laboratory and translational aspects of epilepsy research. Prior work has included: electrical deep brain stimulation for epilepsy, studied in laboratory models and clinical trials; drug delivery to a seizure focus; mechanisms of absence epilepsy studied with in vitro slices of brain thalamus; hyperthermic seizures; diagnosis and treatment of non-epileptic seizures, the post-ictal state; driving and epilepsy; new antiepileptic drugs; surgery for epilepsy.

  • Kara Flavin, MD

    Kara Flavin, MD

    Clinical Assistant Professor, Neurology & Neurological Sciences

    Current Research and Scholarly Interests Current research interest is stroke recovery, including use of virtual reality and robotics for post-stroke rehabilitation.

  • David Gate

    David Gate

    Instructor, Neurology & Neurological Sciences

    Bio Dr. Gate received his graduate degree in Integrative Biology of Disease from the University of Southern California in 2015. He joined the Wyss-Coray lab in Stanford Neurology as a postdoctoral fellow in 2015 to explore the role of adaptive immunity in neurodegeneration in collaboration with the Stanford Alzheimer?s Disease Research Center. His work focuses on the interplay between T cells and neurodegenerative disease antigens. For this work, he has received an NIH/NINDS K99, Alzheimer?s Association Young Investigator Award and a Junior Faculty Award from the AD/PD Congress. Dr. Gate joined the Stanford Neurology faculty at the Instructor level in December 2020.

  • Paul George, MD, PhD

    Paul George, MD, PhD

    Assistant Professor of Neurology and, by courtesy, of Neurosurgery

    Current Research and Scholarly Interests CONDUCTIVE POLYMER SCAFFOLDS FOR STEM CELL-ENHANCED STROKE RECOVERY:
    We focus on developing conductive polymers for stem cell applications. We have created a microfabricated, polymeric system that can continuously interact with its biological environment. This interactive polymer platform allows modifications of the recovery environment to determine essential repair mechanisms. Recent work studies the effect of electrical stimulation on neural stem cells seeded on the conductive scaffold and the pathways by which it enhances stroke recovery Further understanding the combined effect of electrical stimulation and stem cells in augmenting neural repair for clinical translational is a major focus of this research going forward.

    BIOPOLYMER SYSTEMS FOR NEURAL RECOVERY AND STEM CELL MODULATION:
    The George lab develops biomaterials to improve neural recovery in the peripheral and central nervous systems. By controlled release of drugs and molecules through biomaterials we can study the temporal effect of these neurotrophic factors on neural recovery and engineer drug delivery systems to enhance regenerative effects. By identifying the critical mechanisms for stroke and neural recovery, we are able to develop polymeric technologies for clinical translation in nerve regeneration and stroke recovery. Recent work utilizing these novel conductive polymers to differentiate stem cells for therapeutic and drug discovery applications.

    APPLYING ENGINEERING TECHNIQUES TO DETERMINE BIOMARKERS FOR STROKE DIAGNOSTICS:
    The ability to create diagnostic assays and techniques enables us to understand biological systems more completely and improve clinical management. Previous work utilized mass spectroscopy proteomics to find a simple serum biomarker for TIAs (a warning sign of stroke). Our study discovered a novel candidate marker, platelet basic protein. Current studies are underway to identify further candidate biomarkers using transcriptome analysis. More accurate diagnosis will allow for aggressive therapies to prevent subsequent strokes.

  • Carl Gold

    Carl Gold

    Clinical Assistant Professor, Neurology & Neurological Sciences

    Bio Dr. Gold is a board-certified general neurologist who is fellowship-trained in the diagnosis and treatment of neurological disorders in hospitalized patients. He cares for a broad range of patients, including individuals with seizures, central nervous system infections, autoimmune diseases, headaches, neuromuscular conditions, and neurological complications of cancer. Dr. Gold has a particular clinical interest in the inpatient diagnosis of uncommon or rare neurological disorders. He directs quality improvement for the department of Neurology and is actively involved in projects to improve the experience of hospitalized patients with neurological conditions at Stanford. His primary research interest focuses on enhancing the communication skills of neurology residents and he serves as the Director of the Stanford Neurology Residency Communication Coaching Program. He is also the Fellowship Director of the Stanford Neurohospitalist Fellowship.

    For more information on the Stanford Neurohospitalist Program & Fellowship, please visit: https://med.stanford.edu/neurology/divisions/neurohospitalist.html

    Additional information on Stanford Neurology's efforts in Quality, Safety, & Value can be found here: http://med.stanford.edu/neurology/quality.html

    Learn more about the Stanford Neurology Communication Coaching Program by visiting: http://med.stanford.edu/neurology/education/resident-coaching.html

  • Olga Fedin Goldberg

    Olga Fedin Goldberg

    Clinical Assistant Professor, Neurology & Neurological Sciences

    Bio Dr. Goldberg is board-certified in Neurology by the American Board of Psychiatry and Neurology. She provides comprehensive neurologic care to patients with a broad range of neurologic conditions, including those who have multiple neurologic conditions. She is interested in medical education for neurology residents and for referring primary care providers and serves as Director of Neurology Resident Continuity Clinic. Additionally, she completed the Stanford CELT (Clinical Education Leadership Training) Program for developing skills in quality improvement. She has led or played a key role in multiple quality improvement projects in the Department of Neurology, including those focused on increasing patient understanding of their neurologic medications upon hospital discharge, improvement of outcomes for headache patients seen in primary care, and in optimizing clinic processes involved in collection of cerebrospinal fluid.

  • Neelam Goyal, MD

    Neelam Goyal, MD

    Clinical Associate Professor, Neurology & Neurological Sciences

    Current Research and Scholarly Interests Dr. Goyal specializes in the diagnosis, management, and electrophysiological testing of neuromuscular diseases. Her clinical interests include immune-mediated neuromuscular disorders (myositis, myasthenia gravis, CIDP, and vasculitis) and ALS. She performs SFEMG for diagnosis of neuromuscular junction disorders, and provides botulinum toxin for treatment of sialorrhea for ALS patients.

  • Gerald Grant, MD, FACS

    Gerald Grant, MD, FACS

    Botha Chan Endowed Professor and Professor, by courtesy, of Neurology

    Current Research and Scholarly Interests Dr. Grant directs a Blood-brain Barrier Translational Laboratory focusing on enhancing drug delivery to brain tumors in children.

  • Maxwell Greene, MD

    Maxwell Greene, MD

    Clinical Assistant Professor, Neurology & Neurological Sciences

    Bio Dr. Greene is a board-certified, fellowship-trained neurologist. He is also a Clinical Assistant Professor of Neurology at Stanford University School of Medicine.

    Dr. Greene provides clinical care for adult patients with disorders of the muscles and peripheral nerves that cause weakness and numbness. He specializes in diagnosing and treating neuromuscular diseases that include amyotrophic lateral sclerosis (ALS), all types of muscular dystrophy, chronic inflammatory demyelinating polyneuropathy (CIDP), myasthenia gravis, and Charcot-Marie-Tooth (CMT). For CIDP and CMT, Stanford is one of the few centers of excellence in the country.

    A significant part of Dr. Greene?s practice involves investigational work, where he seeks to determine the cause of a patient?s symptoms. In addition to performing the full range of diagnostic tests including interpreting biopsy procedures, he has special qualifications in electrodiagnosis and the use of electromyography and nerve conduction studies.

    Treatments offered by Dr. Greene cover the complete spectrum of options, with an emphasis on immune therapies for certain conditions. For CIDP and myasthenia gravis, he administers immune globulin, steroids, plasmapheresis, and rituximab. To help manage symptoms of CMT and support areas of the body weakened by this disease, he can recommend physical therapy, occupational therapy, and foot, ankle, and knee orthotics.

    For the treatment of ALS and muscular dystrophy, Dr. Greene leads a multidisciplinary team offering physical and occupational therapy, pulmonary expertise, speech and swallow expertise, nutrition counseling, social services, and specialized nursing, and works together with genetic counseling. All team members collaborate closely to ensure patients receive the care and comfort needed to meet their emotional as well as physical needs.

    As part of his commitment to advancing patients? treatment options, Dr. Greene conducts clinical research. Among his current interests are
    innovative new therapies for ALS and other nerve and muscular disorders. This is an exciting time in the field of neuromuscular medicine, with real potential for treatment breakthroughs for the first time in decades. Exploring these new directions enables Dr. Greene to offer Stanford patients access to options that may not be available anywhere else.

    To highlight new advances for his peers, Dr. Greene has made national and regional presentations at conferences including the American Academy of Neurology meeting. Topics include the results of a study supported in part by the National Institutes of Health: paraneoplastic antibodies as markers of Hodgkin?s disease. JAMA Neurology published Dr. Greene?s article on this research.

    Dr. Greene?s achievements have earned recognition from the American Academy of Neurology and other organizations. He is also the recipient of a travel award from the American Neurological Association and a grant from the NIH National Institute of Neurological Disorders and Stroke.

    A member of the American Academy of Neurology, Dr. Greene is also an active member of the Western ALS Consortium and Northeastern ALS Consortium.

  • Michael Greicius, MD, MPH

    Michael Greicius, MD, MPH

    Iqbal Farrukh and Asad Jamal Professor

    Current Research and Scholarly Interests As the Medical Director of the Stanford Center for Memory Disorders and Principal Investigator of the Stanford Extreme Phenotypes in Alzheimer's Disease (StEP AD) Cohort, Dr. Greicius' research focuses on elucidating the neurobiologic underpinnings of AD. His lab combines cutting edge brain imaging, "deep" phenotyping, and whole-genome sequencing of human subjects to identify novel pathways involved in AD pathogenesis. The goal of his work is to develop effective treatment for AD patients.

  • Jin S. Hahn, MD

    Jin S. Hahn, MD

    Professor of Neurology at the Stanford University Medical Center, Emeritus

    Current Research and Scholarly Interests 1. Clinical informatics and electronic health records
    2. Neonatal and fetal neurology
    3. Prenatal diagnosis neurodevelopmental anomalies
    4. Personalized Health and Wellness Records

  • May Han, MD

    May Han, MD

    Associate Professor of Neurology

    Current Research and Scholarly Interests Multiple sclerosis
    Neuromyelitis optica
    Autoimmune CNS disorders

  • Melanie Hayden Gephart

    Melanie Hayden Gephart

    Associate Professor of Neurosurgery and, by courtesy, of Neurology

    Bio I am a brain tumor neurosurgeon, treating patients with malignant and benign tumors, including glioma, brain metastases, meningioma, vestibular schwannoma, and pituitary adenomas. Our lab seeks greater understanding of the genetic and epigenetic mechanisms driving tumorigenesis and disease progression in malignant brain tumors. We currently study the capacity of cellular and cell-free nucleic acids to inform cancer biology and response to therapy. We also use single cell and cell subtype-specific transcriptomics to identify and target infiltrating glioblastoma. We use these techniques to identify mechanisms of tumor migration, and to stop tumor growth. Our laboratory is a unique and collaborative working environment, engaged in a dynamic research environment at Stanford. Our laboratory space lies at the heart of the Stanford campus between the core campus and the medical facilities, emblematic of the translational aspects of our work.

    www.GephartLab.com
    www.GBMseq.org
    https://stan.md/BrainMets

  • Zihuai He

    Zihuai He

    Assistant Professor (Research) of Neurology and of Medicine (BMIR)

    Bio Dr. He received his PhD from the University of Michigan in 2016. Following a postdoctoral training in biostatistics at Columbia University, he joined Stanford University as an assistant professor of neurology and of medicine in 2018. His research is concentrated in the area of statistical genetics and integrative analysis of omics data, with the aim of developing novel statistical and computational methodologies for the identification and interpretation of complex biological pathways involved in human diseases, particularly neurological disorders. His methodology interest includes high-dimensional data analysis, correlated (longitudinal, familial) data analysis and machine learning algorithms.

  • Jaimie Henderson, MD

    Jaimie Henderson, MD

    John and Jene Blume - Robert and Ruth Halperin Professor, Professor of Neurosurgery and, by courtesy, of Neurology

    Current Research and Scholarly Interests My research interests encompass several areas of stereotactic and functional neurosurgery, including frameless stereotactic approaches for therapy delivery to deep brain nuclei; cortical physiology and its relationship to normal and pathological movement; brain-computer interfaces; and the development of novel neuromodulatory techniques for the treatment of movement disorders, epilepsy, pain, and other neurological diseases.

Stanford Medicine Resources: